Syndax Pharmaceuticals Announces Inducement Stock Option Grants to New Employees

Syndax Pharmaceuticals granted inducement awards to purchase up to 11,600 shares of common stock to two new employees under its 2023 Inducement Plan. The stock options will vest over four years, with 25% vesting on the one-year anniversary and 1/48th vesting monthly thereafter, subject to the employees' continued service relationship with Syndax. The company is a commercial-stage biopharmaceutical company advancing innovative cancer therapies.